Psyence Biomedical Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Psyence Biomedical Ltd
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Psyence Biomedical Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Psyence Biomedical Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Psyence Biomedical Ltd is PBM:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Psyence Biomedical Ltd has its primary listing on NASDAQ. You can trade Psyence Biomedical Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Psyence Biomedical Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Psyence Biomedical Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Psyence Biomedical Ltd.